Cas 41875-18-7,3-(4-(dimethylamino)phenyl)-2-(trifluoromethyl)acrylicacid

41875-18-7

Post Buying Request

Basic information

Product Name: 3-(4-(dimethylamino)phenyl)-2-(trifluoromethyl)acrylicacid
Synonyms: 3-(4-(dimethylamino)phenyl)-2-(trifluoromethyl)acrylicacid
CAS NO:41875-18-7
Molecular Formula:
Molecular Weight: 259.228
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(4-(dimethylamino)phenyl)-2-(trifluoromethyl)acrylicacid(CAS DataBase Reference)
NIST Chemistry Reference: 3-(4-(dimethylamino)phenyl)-2-(trifluoromethyl)acrylicacid(41875-18-7)
EPA Substance Registry System: 3-(4-(dimethylamino)phenyl)-2-(trifluoromethyl)acrylicacid(41875-18-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 41875-18-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

41875-18-7 Suppliers

Recommended suppliers

41875-18-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 41875-18-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,8,7 and 5 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 41875-18:
(7*4)+(6*1)+(5*8)+(4*7)+(3*5)+(2*1)+(1*8)=127
127 % 10 = 7
So 41875-18-7 is a valid CAS Registry Number.

41875-18-7Upstream product

41875-18-7Downstream Products

41875-18-7Relevant academic research and scientific papers

Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR

Basu, Debjit,Richters, André,Rauh, Daniel

, p. 2767 - 2780 (2015)

The clinical success of covalent kinase inhibitors in the treatment of EGFR-dependent non-small cell lung cancer (NSCLC) has rejuvenated the appreciation of reactive small molecules. Acquired drug resistance against first-line EGFR inhibitors remains the

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 41875-18-7